¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Multiple valve disorders in diseases classified elsewhere"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® MVP(=mitral valve prolapse) ÇÑ±Û ½Â¸ðÆÇ Å»ÃâÁõ
¼³¸í   
  ½Â¸ðÆÇÀÌ Á½ɽǿ½Ã Á¦´ë·Î ´ÝÇôÁÖÁö ¸øÇ졒ʼüÁ®³ª¿À´Â »óÅ·μ­ ÁַΠÀþÀº ¿©¼º¿¡°Ô¼­ ¹ß°ßµÈ´Ù. ´Ù¸¥ ¸»·Î Ã»Áø»óÀÇ ¼Ò°ßÀ» µû¼­ ¡°click¡©murmur syndrome¡±À̶ó°íµµ Çϰí È¤Àº Ã³À½ ¹ß°ßÇÑ ÀÇ»çÀÇ À̸§À» µû¼­ ¡°Barlow's syndrome¡±À̶ó°íµµ ÇÑ´Ù. °³ Á¤»óÀûÀΠ»îÀ» ´©¸®°Ô µÇ³ª, ÀϺο¡¼­ ½É³»¸·¿°(½ÉÀå³»¸·ÀÇ ¿°Áõ: endocarditis)ÀÇ À§ÇèÀÌ Áõ°¡ÇϹǷΠġ°úÀû ½Ã¼ú½Ã ¿¹¹æÀû Ç×»ýÁ¦°¡ ÇÊ¿äÇϱ⵵ ÇÏ´Ù.
  
  
¿µ¹® mitral valve ÇÑ±Û ½Â¸ðÆÇ¸·
¼³¸í   
  Á½ɽǰú Á½ɹæ»çÀÌ¿¡ Á¸ÀçÇϴ ÆÇ¸·. 2°³ÀÇ ¸·À¸·Î ³ª´©¾îÁ® ÀÖÀ¸¸ç, ¹ØÀ¸·Î ½É±Ù°ú ¿¬°áµÇ¾î ÀÖ´Ù.
¿µ¹® tricuspid valve ÇÑ±Û ¿À¸¥¹æ½ÇÆÇ¸·, »ï÷ÆÇ¸·
¼³¸í   
  »ç¶÷°ú Æ÷À¯·ù ½ÉÀåÀÇ ¿ì½É¹æ°ú ¿ì½É½Ç »çÀÌ¿¡ Àִ ÆÇ. ¿ìÃø ¹æ½Ç±¸(½É¹æ°ú ½É½ÇÀ» ¿¬¶ôÇϴ ±¸¸Û) ÁÖÀ§¿¡¼­ ½ÃÀ۵Ǵ ¼¼ °³ÀÇ ¾ãÀº ÆÇ¸·°ú, ±× ÀÚÀ¯¿¬¿¡ ºÎÂøµÇ¾î Àִ ¸¹Àº ²öÀ¸·Î µÇ¾î ÀÖ´Ù. °Ç»èÀº °áÇÕÁ¶Á÷À¸·Î µÈ °¡´Â ²öÀε¥, ±× ¹Ý´ëÂÊ ³¡ÀÇ ÀϺδ ¿ì½É½Çº®¿¡ ºÎÂøµÇ°í, ÀϺδ ½É½Çº®¿¡¼­ »¸¾î³ª¿Â À¯µÎ±Ù¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. ÀÌ ÆÇ¸·ÀåÄ¡´Â ½É½ÇÀÌ À̿ϵǾî ÀÖÀ» ¶§ ¿ì½É¹æÀ¸·ÎºÎÅÍ ¿ì½É½Ç·Î Èê·¯µé¾î°£ Ç÷¾×ÀÌ ½É½ÇÀÌ ¼öÃàÇÒ ¶§¿¡ ½É¹æÀ¸·Î ¿ª·ùÇϴ °ÍÀ» ¸·´Â °ÍÀ¸·Î¼­ ¿ÞÂÊ¿¡ Àִ ÀÌ÷ÆÇ¿¡ ÇØ´çµÈ´Ù.
¿µ¹® prosthetic valve ÇÑ±Û ÀΰøÆÇ¸·
¼³¸í   
  ½ÉÀå ³»ºÎÀÇ ÀΰøÆÇ¸·. ½ÉÀåÀÇ ÆÇ¸·ÀÌ ¾î¶² ¿øÀÎÀ¸·Î ¼Õ»óµÇ¾î ÆÇ¸·ÀÇ ±â´ÉÀÌ À¯ÁöµÉ ¼ö ¾øÀ» ¶§ ÀÌ ÆÇ¸·À» ¼ºÇüÇØ¼­ ´Ù½Ã »ç¿ëÇϰųª(ÆÇ¸·¼ºÇü¼ú) ÀΰøÆÇ¸·À¸·Î Ä¡È¯(ÆÇ¸·Ä¡È¯¼ú)ÇØ ÁÖ¾î¾ß ÇÑ´Ù. ÀΰøÆÇ¸·¿¡´Â Å©°Ô µÎ °¡Áö°¡ Àִµ¥ Çϳª´Â µÅÁö³ª ¼Ò µîÀÇ »ýüÁ¶Á÷À¸·Î ¸¸µç Á¶Á÷ÆÇ¸·ÀÌ°í ´Ù¸¥ Çϳª´Â ±Ý¼ÓÀçÁú·Î ¸¸µç ±â°èÆÇ¸·ÀÌ´Ù. ÀÌ µÎ ÆÇ¸·Àº ¼­·Î Àå´ÜÁ¡ÀÌ Àִµ¥, Á¶Á÷ÆÇ¸·Àº ¼ö¸íÀÌ 10³â Á¤µµ·Î ÂªÀº ´ÜÁ¡ÀÌ Àִ ¹Ý¸é¿¡ ÆÇ¸· ÁÖÀ§¿¡ Ç÷¾×ÀÀ°í°¡ Àû¾î Ç×ÀÀ°íÁ¦ º¹¿ëÀÌ Çʿ䠾ø°í, ¼Õ»óÀÌ ¼­¼­È÷ ÀϾ´Ù.
¿µ¹® valve ÇÑ±Û ÆÇ¸·
¼³¸í   
  °ü È¤Àº Åë·Î¿¡ Àִ ¸·°ú °°Àº ÁÖ¸§. ³»¿ë¹°ÀÇ ¿ª·ù¸¦ ¸·´Â´Ù.
  
  1.½ÉÀåÆÇ¸·: ¿ì½É¹æ°ú ¿ì½É½Ç»çÀÌÀÇ »ï÷ÆÇ, Á½ɹæ°ú Á½ɽǻçÀÌÀÇ ½Â¸ðÆÇ, ¿ì½É½Ç°ú Æóµ¿¸Æ»çÀÌÀÇ Æóµ¿¸Æ¹Ý¿ùÆÇ, Á½ɽǰú ´ëµ¿¸Æ»çÀÌÀÇ ´ëµ¿¸Æ¹Ý¿ùÆÇÀÌ ÀÖ´Ù.
  
  2.Á¤¸ÆÆÇ¸·: Á¤¸Æ¿¡¼­ ¹ß°ßµÇ´Â ³»¸·ÀÇ ÀÛÀº Ã· È¤Àº ÁÖ¸§. Åº·Â¼ºÀÌ Àû¾î ¿ª·ùµÇ±â ½¬¿î Á¤¸ÆÇ÷ÀÇ È帧À» ¿ª·ù¾øÀÌ Á¤»óÀûÀΠ¹æÇâÀ¸·Î Áö¼ÓµÇµµ·Ï ÇØÁØ´Ù.
  
  3.ÀΰøÆÇ¸·: ½ÉÀåÆÇ¸·ºÎÁ·À̳ª ½ÉÀåÆÇ¸·ÇùÂøÀÌ À־õÀÌ»ó ÀÚ½ÅÀÇ ÆÇ¸·À¸·Î´Â »ýÁ¸ÀÌ ºÒ°¡´ÉÇÒ ¶§ ´ë½Å À̽ÄÇϰԠµÇ´Â ÀΰøÆÇ¸·À» ¸»ÇÑ´Ù. Å©°Ô µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °Í°ú ±×·¸Áö ¾ÊÀº °ÍÀ¸·Î ¾çºÐÇÒ ¼ö ÀÖ´Ù. µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °ÍÀº ÁַΠµÅÁö³ª ¼ÒÀÇ ÆÇ¸· ¶Ç´Â ½É¿Ü¸· µîÀ» ÀÌ¿ëÇϸç, ±×·¸Áö ¾ÊÀº °ÍÀº Æ¯¼öÇÑ ±Ý¼ÓÀ» ÀÌ¿ëÇÏ¿© ¸¸µç´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • prosthetic valve
    ÀΰøÆÇ¸·
  • prosthetic valve replacement
    ÀΰøÆÇ¸·´ëÄ¡(¼ú)
  • pulmonary valve
    Æóµ¿¸ÆÆÇ, ÇãÆÄµ¿¸ÆÆÇ
  • rectal valve
    Á÷ÀåÆÇ¸·, °ðâÀÚÆÇ¸·
  • right atrioventricular valve
    ¿À¸¥¹æ½ÇÆÇ¸·, ¿ì¹æ½ÇÆÇ¸·
  • valve
    1. ÆÇ¸·, ÆÇ 2. ¹ëºê
  • valve cusp
    ÆÇ¸·Ã·ÆÇ
  • valve incisor
    ÆÇ¸·Àý°³µµ, ÆÇ¸·Àý°³Ä®
  • valve regurgitant area
    ÆÇ¸·¿ª·ùºÎÀ§
  • hereditary multiple exostosis
    À¯Àü´Ù¹ß»Àµ¹ÃâÁõ, À¯Àü´Ù¹ß¿Ü°ñÁõ
  • multiple
    ´Ù¹ß-, ¿©·¯-, ¹µ-, ´Ù¼ö-, ´ÙÁß-, ´Ù-
  • multiple abscess
    ¹µ°í¸§Áý, ´Ù¹ß³ó¾ç
  • multiple allele
    ¹µ¸Â¼¶À¯ÀüÀÚ, º¹¼ö´ë¸³À¯ÀüÀÚ
  • multiple birth
    ´Ùžƺи¸
  • multiple bond
    ´ÙÁß°áÇÕ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • one-way valve
    ÀϹæÆÇ¸·
  • posterior urethral valve
    µÚ¿äµµÆÇ¸·
  • prosthetic valve
    ÀΰøÆÇ¸·
  • right atrioventricular valve
    »ï÷ÆÇ¸·, ¿À¸¥¹æ½ÇÆÇ¸·
  • tricuspid valve
    (¢¡ right atrioventricular valve) »ï÷ÆÇ¸·, ¿À¸¥¹æ½ÇÆÇ¸·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • expiratory valve
    È£±âÆÇ¸·
  • frenulum of ileocecal valve
    µ¹¸·Ã¢ÀÚÆÇ¸·ÁÖ¸§¶ì
  • fail safe valve
    ¾ÈÀüÀåÄ¡ÆÇ¸·
  • ileocecal valve
    µ¹¸·Ã¢ÀÚÆÇ¸·
  • inhalation valve
    ÈíÀÔÆÇ¸·
  • inspiratory valve
    Èí±âÆÇ¸·
  • valve incisor
    ÆÇ¸·Àý°³µµ
  • mitral valve
    ½Â¸ðÆÇ, ¿Þ¹æ½ÇÆÇ¸·
  • mitral valve prolapse
    ½Â¸ðÆÇÅ»ÃâÁõ
  • mitral valve replacement
    ½Â¸ðÆÇ´ëÄ¡¼ú, ¿Þ¹æ½ÇÆÇ¸·´ëÄ¡¼ú
  • one-way valve
    ÀϹæÆÇ¸·
  • oxygen flush valve
    »ê¼ÒºÐÃâÆÇ¸·
  • pop off valve
    ¹è±âÆÇ¸·
  • prosthetic valve
    ÀΰøÆÇ¸·
  • prosthetic valve replacement
    ÀΰøÆÇ¸·Ä¡È¯¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemostatic disorders
    Ç÷¾×ÀÀ°íÁúȯ
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • platelet function disorders
    Ç÷¼ÒÆÇ±â´ÉÀÌ»óÁúȯ
  • postpartum disorders
    »êÈÄ Àå¾Ö(º´)
  • psychogenic voice disorders
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • CVS=£¾closing valve sound
    Æó¼â¿ëÀûÀ½.
  • Hasner valve
    ÇϽº³ÊÆÇ
  • Ileocecal valve
    ȸ¸ÍÆÇ(üÞØî÷ù)
  • Insufficiency, cardiac valve
    ½ÉÀåÆÇ¸·ºÎÀüÁõ(ãýíô÷ûدÜôîïñø)
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • adjustable pressure limiting valve
    Á¶ÀýÇü ¾Ð·ÂÁ¦ÇÑ ¹ëºê.
  • anterior semilunar valve
    ¾Õ¹Ý´ÞÆÇ¸·
  • antirflux valve
    Ç׿ª·ù ÆÇ¸·
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rickettsial diseases
    ¸®ÄÉÄ¡¾Æº´(¡­Ü»).
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • autosomal dominant disorders
    »ó¿°»öü ¿ì¼ºÁúȯ(ßÓæøßäô÷éÐàõòðü´)
  • autosomal recessive disorders
    »ó¿°»öü ¿­¼ºÁúȯ(¡­Ö«àõòðü´)
  • chromosomal disorders
    ¿°»öü Áúȯ (¡­òðü´)
  • collagen-vascular disorders
    ÄݶóÁ¨-Ç÷°üÁúȯ(¡­úìηòðü´)
  • congenital disorders of the larynx
    ¼±Ãµ(¼º) ÈĵÎÁúȯ
  • cutaneous disorders
    ÇǺÎÁúȯ
  • cytogenetic disorders
    ¼¼Æ÷À¯ÀüÀå¾Ö(¡­ë¶îîî¡äô)
  • diaphragm disorders
    Ⱦ°æ¸·ÀÌ»ó
  • disorders of articulation
    ±³ÇÕÀå¾Ö(Îáùê î¡äô).
  • disorders of sensation
    Áö°¢Àå¾Ö(ò±ÊÆî¡äô).
  • electrolyte disorders
    ÀüÇØÁúÀÌ»ó(ï³ú°òõì¶ßÒ).
  • electrolyte disorders
    ÀüÇØÁúÀÌ»ó.
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lunulae of semilunar valve
    ¹Ý´ÞÆÇ¸·Á¶°¢
    [¿¾ ¿ë¾î] ¹Ý¿ùÆÇ¹Ý¿ù
  • Atrioventricular valve
    ½É¹æ½É½ÇÆÇ¸·
    [¿¾ ¿ë¾î] ¹æ½ÇÆÇ
  • Valve of conary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸Æµ¿ÆÇ
  • Valve of coronary sinus
    ½ÉÀåÁ¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] °ü»óÁ¤¸ÆÆÇ
  • Valve of inferior vena cava
    ¾Æ·¡´ëÁ¤¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] ÇÏ´ëÁ¤¸ÆÆÇ
  • Anterior semilunar valve
    ¾Õ¹Ý´ÞÆÇ¸·
    [¿¾ ¿ë¾î] Àü¹Ý¿ùÆÇ
  • Right semilunar valve
    ¿À¸¥¹Ý´ÞÆÇ¸·
    [¿¾ ¿ë¾î] ¿ì¹Ý¿ùÆÇ
  • Tricuspid valve
    ¿À¸¥½É¹æ½É½ÇÆÇ¸· [»ï÷ÆÇ¸·]
    [¿¾ ¿ë¾î] »ï÷ÆÇ
  • Left semilunar valve
    ¿Þ¹Ý´ÞÆÇ¸·
    [¿¾ ¿ë¾î] Á¹ݿùÆÇ
  • Valve of sinus venosus
    Á¤¸Æµ¿±¼ÆÇ¸·
    [¿¾ ¿ë¾î] Á¤¸Æµ¿ÆÇ
  • Venous valve
    Á¤¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Á¤¸ÆÆÇ
  • Valve of oval foramen
    Ÿ¿ø±¸¸ÛÆÇ¸·
    [¿¾ ¿ë¾î] ³­¿ø°øÆÇ
  • Valve
    ÆÇ¸·
    [¿¾ ¿ë¾î] ÆÇ
  • Bulboventricular valve
    ÆØ´ë½É½ÇÆÇ¸·
    [¿¾ ¿ë¾î] ±¸½É½ÇÆÇ
  • Pulmonary valve
    ÇãÆÄµ¿¸ÆÆÇ¸·
    [¿¾ ¿ë¾î] Æóµ¿¸ÆÆÇ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bicuspid valve
    ÀÌ÷ÆÇ
  • check valve mechanism
    ýº§ºê±âÀü
  • ileocecal valve
    ȸ¸ÍÆÇ
  • mitral valve
    ½Â¸ðÆÇ¸·, ½Â¸ðÆÇ
  • mitral valve prolapse
    ½Â¸ðÆÇÅ»ÃâÁõ
  • mitral valve replacement
    ½Â¸ðÆÇ´ëÄ¡(¼ú), ½Â¸ðÆÇġȯ
  • predictive valve
    ÃßÁ¤µµ
  • prosthetic valve
    ÀΰøÆÇ¸·
  • prosthetic valve replacement
    ÀΰøÆÇ¸·´ëÄ¡¼ú
  • pulmonary valve
    Æóµ¿¸ÆÆÇ
  • semilunar valve
    ¹Ý¿ùÆÇ
  • semilunar valve
    ¹Ý¿ù»óÆÇ
  • tricuspid valve
    »ï÷ÆÇ
  • ureterovesical valve
    ¿ä°ü¹æ±¤ÆÇ¸·
  • valve
    ÆÇ¸·, ÆÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PRAGMATIC pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi...
DDRT diseases, disorders and related topics
NINCDS/ADRDA National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Rel...
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
AVA activity vector analysis; antiviral antibody; aortic valve area; aortic valve atresia; arteriovenous...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HCD Heavy chain diseases
ICD9CM International Classification of Diseases 9th Revision Clinical Modification
ICD-9 CM International Classification of Diseases, Ninth Revision, Clinical Modification
LSD Lysosomal storage diseases
NMD Neuromuscular Diseases
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • left semilunar valve
    ¿Þ¹Ý´ÞÆÇ¸·, ÁÂÃø ¹Ý¿ùÆÇ, Á ¹Ý¿ùÆÇ
  • mild pulmonary valve stenosis
    °æµµÀÇ Æó µ¿¸ÆÆÇ ÇùÂøÁõ
  • mitral valve prolapse
    ½Â¸ðÆÇ Å»ÃâÁõ
  • nasal valve
    ºñ ¹ßºê, ÄÚ ¹®Â¦
  • opening of ileocecal valve
    µ¹¸·Ã¢ÀÚ ÆÇ¸· ±¸¸Û
  • prosthetic valve
    Àΰø ÆÇ¸·
    ÁúȯÀ̳ª ¼±ÃµÀûÀ¸·Î ÀÌ»óÀÌ ÀÖ´Â ÆÇ¸·À» Àΰø Àç·á¸¦ ÀÌ¿ëÇÏ¿© ´ëÄ¡ÇÏ´Â °Í.
  • pulmonary valve
    Æó µ¿¸ÆÆÇ
  • rectal valve
    Á÷Àå ¹ßºê
  • right atrioventricular valve
    ¿À¸¥ ¹æ½Ç ÆÇ¸·, ¿ì¹æ½Ç ÆÇ
  • right semilunar valve
    ¿ì ¹Ý¿ùÆÇ
  • safety valve
    ¾ÈÀü ÆÇ
  • tissue valve
    Á¶Á÷ ÆÇ¸·
    µ¿ÀǾî=bio
  • tricuspid valve replacement
    »ï÷ÆÇ ġȯ¼ú
    »ï÷ ÆÇ¸·Àº º´º¯ÀÇ ´ëºÎºÐÀÌ ÁÂÃø¿¡ ¹ß»ýÇÑ ½Â¸ð ÆÇ¸·À̳ª ´ëµ¿¸Æ ÆÇ¸·ÀÇ ºÎÀüÀ¸·Î ÀÎÇØ 2Â÷ÀûÀ¸·Î ¹ß»ýÇÏ´Â °ÍÀÌ °¡Àå ÈçÇÏÁö¸¸ ¶§·Î´Â »ï÷ ÆÇ¸· ÀÚü¿¡µµ ½ÉÇÑ º¯ÇüÀÌ ¿Í¼­ ÆÇ¸·À» Ä¡È¯ÇØ¾ß ÇÒ ¶§µµ ÀÖ´Ù. ¶Ç ¾î¶² ¼±Ãµ¼º Áúȯ Áï ¿¦½ºÅ¸ÀÎ ±âÇü µî¿¡¼­µµ ÆÇ¸·ÀÇ ¼ºÇü¼úÀÌ ºÒ°¡´ÉÇÏ¿© ÆÇ¸·À» Ä¡È¯ÇØ¾ß ÇÒ ¶§µµ Àִµ¥ º¸ÅëÀº ÃÊÀ½ÆÄ Áø´ÜÀÌ Á¤È®Çϱ⠶§¹®¿¡ ¼ö¼ú Àü¿¡ ¾î´À Á¤µµ ÁüÀÛÀ» ÇÒ ¼ö ÀÖ´Ù. ġȯµÇ´Â ÆÇ¸·Àº Á¶Á÷ ÆÇ¸·À» »ç¿ëÇÏ´Â °ÍÀÌ ÀϹÝÀûÀ̳ª ¼ö¸íÀÌ Æò±Õ 10³â¹Û¿¡ ¾ÈµÇ±â ¹®¿¡ ¿µ±¸ÀûÀÎ ±Ý¼Ó ÆÇ¸·À» »ç¿ëÇϱ⵵ ÇÑ´Ù. ±×·¯³ª ¿ìÃø ½ÉÀå Áï »ï÷ ÆÇ¸·À̳ª Æó µ¿¸Æ ÆÇ¸·ÀÇ À§Ä¡¿¡¼­´Â ÀϹÝÀûÀ¸·Î ÁÂÃø ½ÉÀ庸´Ù Ç÷ÀüÀÌ Àß ¹ß»ýÇÏ¿© Á¶Á÷ ÆÇ¸·À» ¼±È£ÇÏ´Â °ÍÀÌ º¸ÅëÀÌ´Ù.
  • unidirectional valve
    ÀÏ¹æ ¹ëºê
  • vacuum valve amplifier
    Áø°ø°ü ÁõÆø±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
multiple drug resistant tuberculosis A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance.
(09 Oct 1997)
multiple ego states Various psychological organizational state's reflecting different personas or life experiences.
(05 Mar 2000)
multiple embolism Embolism caused by the arrest of a number of small emboli.
(05 Mar 2000)
multiple endocrine adenomatosis The presence of functioning tumours in more than one endocrine gland, commonly the pancreatic islets and parathyroid glands, which may be associated with Zollinger-Ellison syndrome; dominant inheritance.
Synonym: multiple endocrine adenomatosis.
(05 Mar 2000)
multiple endocrine deficiency syndrome <syndrome> Acquired deficiency of the function of several endocrine glands, usually on an auto-immune basis.
Synonym: multiple glandular deficiency syndrome.
(05 Mar 2000)
multiple endocrine neoplasia (type I) This is a hereditary disorder in which two or more of the following glands: parathyroid, pancreas, pituitary, adrenals or thyroid develop hyperplasia or a tumour.
(type II) This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
Origin: Gr. Plassein = to form
(27 Sep 1997)
multiple endocrine neoplasia 1 <radiology> Multiple endrocrine neoplasia syndrome three P's.
Pituitary adenoma, 65% can develop Cushing's, acromegaly, prolactinoma, parathyroid hyperplasia / adenoma, 88% can develop hyper-PTH
pancreatic isleT-cell tumour, gastrinoma (Z-E) most common, 50% of Z-E can develop MEN-1, inconstant features: bronchial/intestinal carcinoid, thyroid adenoma, adrenal cortical tumour, lipoma, thymoma tissue expression
Primary hyperparathyroidism (90%), Gastrinoma (30%), Prolactinoma (15%), Other (10%).
Synonym: Wermer syndrome
(12 Dec 1998)
multiple endocrine neoplasia 2 <radiology> Multiple endocrine neoplasia syndrome, medullary thyroid carcinoma, usually multifocal; metastasis to local nodes, lung, liver, usually calcify in liver, pheochromocytoma, almost always bilateral, parathyroid hyperplasia, may be secondary to calcitonin secreted by medullary thyroid carcinoma inconstant feature: adrenal cortical hyperplasia
Synonym: Sipple syndrome
(12 Dec 1998)
multiple endocrine neoplasia 3 <radiology> Multiple endocrine neoplasia syndrome (type 2B, type 3), medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus (Cf: Marfan syndrome), mucosal neuromas, neurofibromas, ganglioneuromatosis coli More info: MEN syndrome 2B
Synonym: Schimke, marfanoid syndrome
(12 Dec 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple epiphysial dysplasia A dominantly inherited abnormality of epiphyses characterised by difficulty in walking, pain and stiffness of joints, stubby fingers, and often dwarfism of short-limb type; on X-ray examination, the epiphyses are mottled and irregular; ossification centres are late in appearance and may be multiple, but the vertebrae are normal. There is also an autosomal recessive form .
Synonym: dysplasia epiphysialis multiplex.
(05 Mar 2000)
multiple exostosis A disturbance of enchondral bone growth in which multiple, generally benign osteochondromas of long bones appear during childhood, commonly with shortening of the radius and fibula; the ill-effects are usually mechanical but malignant change is rare; autosomal dominant inheritance.
Synonym: diaphysial aclasis, hereditary deforming chondrodystrophy, multiple exostosis, osteochondromatosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • clack valve
    ¿ªÇà ¹æÁöÆÇ
  • eduction valve
    (±â)¹è±âÆÇ
  • escape valve
    ¹è±â¹ëºê
  • exhaust valve
    ¹è±â°ü
  • needle valve
    ´Ïµé¹ëºê;ħÆÇ
  • puppet valve
    ¹ö¼¸ ¸ð¾çÀÇ ¾ÈÀüÆÇ
  • relief valve
    ¾ÈÀüÆÇ;¿ÏÈ­ÆÇ
  • safety valve
    ¾ÈÀüÆÇ
  • throttle valve
    Á¶ÀýÆÇ
  • valve
    ÆÇ;ÆÇ(¸·);(½Ö²®ÁúÁ¶°³ÀÇ)Á¶°¡ºñ;(²¿Åõ¸®,Æ÷,±ïÁöÀÇ)ÇÑÁ¶°¢;(°ü¾Ç±âÀÇ)ÆÇ;Áø°ø°ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á